94543 ⎘
Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
Sub-classes:PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS
#2HOLE TRANSPORT PROMOTING MATERIAL, MATERIAL FOR LIGHT RECEIVING ELEMENT, CYANO COMPOUND, AND ORGANIC LIGHT RECEIVING ELEMENT
#3Pyruvate kinase activators for use in treating blood disorders
#4ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
#5Pyruvate kinase activators for use in treating blood disorders
#6Electrochemical reduction of carbon dioxide
#7ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
#8Pyruvate kinase modulators and use thereof
#9Pyruvate kinase activators for use in treating blood disorders
#10HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF
#11Pyruvate kinase activators for use in treating blood disorders
#12ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
#13Pyruvate kinase activators for use in treating blood disorders
#14Pyruvate kinase modulators and use thereof
#15Method for producing fullerene derivative
#16Inhibitors of hepatitis C virus
#17Dicyano N-heterocyclic compound, light-emitting material, and light-emitting element in which same is used
#18Electrophotographic photosensitive member, process cartridge, and image forming apparatus
#19Inhibitors of hepatitis C virus
#20IRIDIUM (III) COMPLEXES WITH CYCLIC QUINOXALINE-FUSED LIGANDS AND ORGANIC LIGHT-EMITTING DIODES USING THE SAME
#21HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF
#22Organic electroluminescent materials and organic electroluminescent devices
#23Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
#24ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
#25INHIBITORS OF HEPATITIS C VIRUS
#26Method for producing fullerene derivative
#27Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
#28Hydrophilic self-immolative linkers and conjugates thereof
#29Hydrophilic self-immolative linkers and conjugates thereof
#30Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
#31Organic electroluminescent element
#32Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
#33Hydrophilic self-immolative linkers and conjugates thereof
#34Metalloinsertor complexes targeted to DNA mismatches
#35Small molecule inhibitors of protein kinases
#36Coferons and methods of making and using them
#37Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
#38Phthalocyanine compound and production method therefor, and coloring composition containing the phthalocyanine compound
#39FUSED BENZOAZEPINES AS NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
#40Small molecules for inhibition of protein kinases
#41Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base
#42a2-Adrenoceptor Ligands
#43UV-filter compounds
#44Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device
#45Acenaphthoquinoxaline derivative, light-emitting element, light-emitting device, and electronic device
#46Colorants based N-halamines compositions and method of making and using
#47Quinoxaline derivative, light-emitting element, light-emitting device, and electronic appliance
#48Quinoxaline Derivative, And Light Emitting Element, Light Emitting Device, And Electronic Device Using the Quinoxaline Derivative
#49Piperazines as P2X7 antagonists
#50α2C adrenoreceptor agonists
#51Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof